PNC Financial Services Group’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-225
| Closed | – | – | 4899 |
|
|
2022
Q3 | $0 | Hold |
225
| – | – | ﹤0.01% | 4694 |
|
|
2022
Q2 | $0 | Hold |
225
| – | – | ﹤0.01% | 4833 |
|
|
2022
Q1 | $0 | Sell |
225
-2,688
| -92% | -$5.28K | ﹤0.01% | 4787 |
|
|
2021
Q4 | $8K | Buy |
2,913
+2,688
| +1,195% | +$9.94K | ﹤0.01% | 3863 |
|
|
2021
Q3 | $1K | Sell |
225
-5,775
| -96% | -$27.8K | ﹤0.01% | 4242 |
|
|
2021
Q2 | $35K | Hold |
6,000
| – | – | ﹤0.01% | 3249 |
|
|
2021
Q1 | $43K | Sell |
6,000
-1,000
| -14% | -$6.71K | ﹤0.01% | 3070 |
|
|
2020
Q4 | $34K | Buy |
7,000
+2,000
| +40% | +$10.1K | ﹤0.01% | 3130 |
|
|
2020
Q3 | $29K | Hold |
5,000
| – | – | ﹤0.01% | 3048 |
|
|
2020
Q2 | $34K | Hold |
5,000
| – | – | ﹤0.01% | 2977 |
|
|
2020
Q1 | $32K | Hold |
5,000
| – | – | ﹤0.01% | 2884 |
|
|
2019
Q4 | $52K | Hold |
5,000
| – | – | ﹤0.01% | 2879 |
|
|
2019
Q3 | $20K | Buy |
5,000
+3,000
| +150% | +$24.3K | ﹤0.01% | 3362 |
|
|
2019
Q2 | $30K | Hold |
2,000
| – | – | ﹤0.01% | 3193 |
|
|
2019
Q1 | $50K | Hold |
2,000
| – | – | ﹤0.01% | 2949 |
|
|
2018
Q4 | $36K | Sell |
2,000
-2,220
| -53% | -$45.4K | ﹤0.01% | 3047 |
|
|
2018
Q3 | $124K | Sell |
4,220
-3,263
| -44% | -$126K | ﹤0.01% | 2470 |
|
|
2018
Q2 | $339K | Buy |
7,483
+2,056
| +38% | +$100K | ﹤0.01% | 1883 |
|
|
2018
Q1 | $287K | Sell |
5,427
-48,871
| -90% | -$2.85M | ﹤0.01% | 1956 |
|
|
2017
Q4 | $3.69M | Buy |
54,298
+50,238
| +1,237% | +$3.51M | ﹤0.01% | 839 |
|
|
2017
Q3 | $334K | Buy |
4,060
+1,240
| +44% | +$98.3K | ﹤0.01% | 1857 |
|
|
2017
Q2 | $265K | Buy |
2,820
+20
| +0.7% | +$1.22K | ﹤0.01% | 1978 |
|
|
2017
Q1 | $179K | Buy |
2,800
+100
| +4% | +$6.08K | ﹤0.01% | 2193 |
|
|
2016
Q4 | $121K | Buy |
2,700
+1,100
| +69% | +$38.7K | ﹤0.01% | 2369 |
|
|
2016
Q3 | $58K | Sell |
1,600
-8
| -0.5% | -$172 | ﹤0.01% | 2763 |
|
|
2016
Q2 | $22K | Sell |
1,608
-2,020
| -56% | -$29.5K | ﹤0.01% | 3230 |
|
|
2016
Q1 | $69K | Buy |
3,628
+3,485
| +2,437% | +$73.8K | ﹤0.01% | 2672 |
|
|
2015
Q4 | $5K | Sell |
143
-912
| -86% | -$58.8K | ﹤0.01% | 3893 |
|
|
2015
Q3 | $97K | Buy |
1,055
+304
| +40% | +$26.3K | ﹤0.01% | 2545 |
|
|
2015
Q2 | $65K | Buy |
751
+247
| +49% | +$21.1K | ﹤0.01% | 2878 |
|
|
2015
Q1 | $37K | Buy |
504
+100
| +25% | +$7.06K | ﹤0.01% | 3201 |
|
|
2014
Q4 | $24K | Sell |
404
-413
| -51% | -$21.7K | ﹤0.01% | 3087 |
|
|
2014
Q3 | $38K | Sell |
817
-2,484
| -75% | -$104K | ﹤0.01% | 2815 |
|
|
2014
Q2 | $136K | Buy |
3,301
+290
| +10% | +$14.9K | ﹤0.01% | 2115 |
|
|
2014
Q1 | $208K | Buy |
+3,011
| New | +$221K | ﹤0.01% | 1875 |
|
|
2013
Q3 | – | Sell |
-250
| Closed | -$17K | – | 3674 |
|
|
2013
Q2 | $17K | Buy |
+250
| New | +$11.2K | ﹤0.01% | 2823 |
|
Other funds holding CLVS
CAS
CASC
STB
FFWM
NFSG
PNC Financial Services Group's CLVS Position: Q4 2022 in Review
PNC Financial Services Group sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 225 shares.
PNC Financial Services Group first reported a position in CLVS in Q2 2013 and held it in 36 quarters. The position peaked at $3.69M in Q4 2017. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.
- PNC Financial Services Group reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
- PNC Financial Services Group sold 225 Clovis Oncology, Inc. shares in Q4 2022.
- PNC Financial Services Group first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 36 quarters.
- PNC Financial Services Group's Clovis Oncology, Inc. position peaked at $3.69M in Q4 2017.
- 15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.
Based on PNC Financial Services Group's 13F filing for Q4 2022, filed 10 Feb 2023.